Specialist R&D Tax & Grant Funding Advisors
Specialist R&D Tax & Grant Funding Advisors
Myriad Associates is proud to announce that 4 of our clients who applied for the Disruptive Technologies Innovation Fund were all approved on Monday 10th December.
With a combined grant value of €14.9m, this will provide a major boost to the MedTech and Cellular Therapy communities in Galway.
The first 27 projects from Ireland’s €500m Disruptive Technologies Innovation Fund (DTIF) were announced this week and will receive a combined €75m in support.
Marc Greatrex, Director of Grants at Myriad Associates commented the success of these applications was a testament to the strength of concepts with the passion, drive and commitment of the SMEs in Galway “We are absolutely thrilled and humbled to have 4 out of 4 applications accepted by the DTIF, we were always hopeful and glad we could help these consortia secure the funding. The technologies they're developing will have a major impact for patients and on the Irish National Strategic Outcomes in the coming years”
The full list of approved projects can be accessed here. They include a scheme to help communities generate their own electricity, new treatments for sepsis, a support system for coastal flooding and advanced 3D printing of medical implants.
The Myriad Associates grant team have done it again. They’ve won over £200,000 worth of funding from UK Research and Innovation (UKRI) as part of their UK-Canada competition.
This May 2021, Innovate UK will invest up to £25 million in the best game-changing or disruptive ideas with a view to commercialisation.
Chancellor Rishi Sunak has laid out his economic plans for the next twelve months with a range of additional business support measures.